|
|
|
|
pmid:
|
Lütjohann D |
Cholesterol metabolism in the brain: importance of 24S-hydroxylation. |
2006 |
Acta Neurol. Scand., Suppl.c |
pmid:16866909
|
Björkhem I et al. |
Oxysterols and Alzheimer's disease. |
2006 |
Acta Neurol. Scand., Suppl.c |
pmid:16866910
|
Fourgeux C et al. |
Steady-state levels of retinal 24S-hydroxycholesterol are maintained by glial cells intervention after elevation of intraocular pressure in the rat. |
2012 |
Acta Ophthalmol |
pmid:22998629
|
Lütjohann D et al. |
Cholesterol dynamics in the foetal and neonatal brain as reflected by circulatory levels of 24S-hydroxycholesterol. |
2001 |
Acta Paediatr. |
pmid:11440099
|
Gamba P et al. |
Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer's disease: three partners in crime. |
2011 |
Aging Cell |
pmid:21272192
|
Gamba P et al. |
Up-regulation of β-amyloidogenesis in neuron-like human cells by both 24- and 27-hydroxycholesterol: protective effect of N-acetyl-cysteine. |
2014 |
Aging Cell |
pmid:24612036
|
Serrano-Pozo A et al. |
Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers. |
2010 Jul-Sep |
Alzheimer Dis Assoc Disord |
pmid:20473136
|
DeBarber AE et al. |
Liquid chromatography-tandem mass spectrometry determination of plasma 24S-hydroxycholesterol with chromatographic separation of 25-hydroxycholesterol. |
2008 |
Anal. Biochem. |
pmid:18555788
|
Raina A and Kaul D |
LXR-α genomics programmes neuronal death observed in Alzheimer's disease. |
2010 |
Apoptosis |
pmid:20927647
|
Locatelli S et al. |
Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. |
2002 |
Arch. Neurol. |
pmid:11843691
|
Vega GL et al. |
Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. |
2003 |
Arch. Neurol. |
pmid:12707064
|
Papassotiropoulos A et al. |
Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. |
2003 |
Arch. Neurol. |
pmid:12533085
|
Björkhem I and Meaney S |
Brain cholesterol: long secret life behind a barrier. |
2004 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:14764421
|
Khenjanta C et al. |
Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression. |
2014 |
Asian Pac. J. Cancer Prev. |
pmid:25556446
|
Burkard I et al. |
Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers. |
2007 |
Atherosclerosis |
pmid:17107679
|
Leoni V and Caccia C |
Study of cholesterol metabolism in Huntington's disease. |
2014 |
Biochem. Biophys. Res. Commun. |
pmid:24525128
|
Fourgeux C et al. |
In vivo consequences of cholesterol-24S-hydroxylase (CYP46A1) inhibition by voriconazole on cholesterol homeostasis and function in the rat retina. |
2014 |
Biochem. Biophys. Res. Commun. |
pmid:24491555
|
Meljon A et al. |
Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse. |
2014 |
Biochem. Biophys. Res. Commun. |
pmid:24491562
|
Baila-Rueda L et al. |
Bile acid synthesis precursors in familial combined hyperlipidemia: the oxysterols 24S-hydroxycholesterol and 27-hydroxycholesterol. |
2014 |
Biochem. Biophys. Res. Commun. |
pmid:24406166
|